SCHEMBL20052040

SCHEMBL20052040

CB(O)N1CCN(C)C(CO)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20052039 0.85 — —
SCHEMBL1183666 0.73 GAA (0.34) —
SCHEMBL1184698 0.73 GAA (0.34) —
SCHEMBL799514 0.73 GAA (0.34) —
SCHEMBL3429440 0.72 MAPK1 (0.40) —
SCHEMBL3428847 0.72 MAPK1 (0.40) —
SCHEMBL14438561 0.72 MAPK1 (0.40) —
SCHEMBL22834149 0.71 — —
SCHEMBL14156694 0.70 — —
SCHEMBL17284483 0.69 GAA (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944658-B2 Beta-lactamase inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2018-04-17 — — US disclosed
Send feedback